can i do intermittent fasting while on semaglutide and Intermittent Fasting Beyond Weight Loss:

Based in Hyderabad, IN 2025 Lorven Biologics

Are overweight, with a BMI of 27 kg/m or higher, and have at least one weight-related health condition

This test maps 14 biological pathways and 49 peptide variantsincluding key markers like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609to identify whether your body naturally produces robust GLP-1 signaling or whether you have genetic factors favoring better response to tirzepatide versus other compounds

Common experiences: Essentially no GI side effects Steady appetite control Weight loss slowing as plateau approaches Improved metabolic markers (blood pressure, cholesterol, blood sugar) Weight loss: Typically 22-27% cumulative by week 48 Management priority: Plan for long-term maintenance